Getting latest data loading
Home / Morning Report / Morning Report – 22nd December 2023

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 22 December 2023

Yesterday’s UK 100 Leaders Price (p) % Chg
Vodafone Group PLC 69.1 2.3%
Anglo American PLC 1,928.0 0.8%
Pearson PLC 957.0 0.7%
HSBC Holdings PLC 623.4 0.7%
BAE Systems PLC 1,093.5 0.6%

 

Yesterday’s UK 100 Laggards Price (p) % Chg
Burberry Group PLC 1,426.5 -4.4%
Ocado Group PLC 756.5 -4.1%
United Utilities Group PLC 1,069.5 -2.8%
Endeavour Mining PLC 1,774.0 -2.2%
Airtel Africa PLC 127.3 -1.9%

 

Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,693 -0.3% 2.4%
DOW JONES INDUS. AVG 37,297 0.6% 11.9%
DAX INDEX 16,674 -0.4% 18.3%
NIKKEI 225 33,140 -1.6% 25.0%
S&P/ASX 200 INDEX 7,504 -0.5% 4.9%

 

Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 73.68 -0.73%
Brent Crude (ICE) USD/bbl. 79.19 -0.64%
Gold Spot USD/t oz. 2,042 0.5%
Copper (Comex) USd/lb. 391 0.1%
The UK 100 called to open -28 points at 7,665

4 hours; 3 Months

Click graph to enlarge

Markets Overview:

The UK 100 called to open -28 points at 7,668.   The UK 100 is expected to open lower on Friday, despite some festive cheer on Wall Street, as investors look ahead to a key US inflation reading.  Data this morning showed that the UK economy shrank in the third quarter increasing the danger of a mild recession, figures showed today.  UK gross domestic product is estimated to have fallen by 0.1% between July to September, revised down from a first estimate of no growth, the Office for National Statistics said.  In the US on Thursday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.9%, the S&P 500 up 1.0% and the Nasdaq Composite up 1.3%.

 

Company News & Broker Comments:

Company News:

AstraZeneca and Ionis’ Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults, commonly referred to as hATTR-PN or ATTRv-PN.1 Wainua is the only approved medicine for the treatment of ATTRv-PN that can be self-administered via an auto-injector.2-4.

 

HSBC sale of its Canadian business to RBC received on 21 December 2023 the Canadian Federal Government’s Minister of Finance approved the sale, with this approval enabling the transaction to proceed.

 

Broker Comments:

 No New Broker Comments

Reporting Today:

UK

 

None

 

 

US

 

None

Reporting Tomorrow:

UK

 

None

 

US

 

None

 

 

In Focus Today:

UK Gross Domestic Product

UK Retail Sales

US Core Personal Consumption Expenditures – Price Index

US Durable Goods Orders

US Personal Consumption Expenditures – Price Index

US Personal Income

US Personal Spending

Michigan Consumer Sentiment Index

New Home Sales Change

 

 

Next Week’s Ex-Dividends:

UK 100 companies going ex-dividend on 28th December 2023:

 

BT Group

 

 

UK 250 companies going ex-dividend on 28th December 2023:

 

 

Schroder AsiaPacific Fund

Grainger

JPMorgan European Discovery Trust

Global Smaller Companies Trust

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.